BridgeMD
New treatment option for Post Coronary Artery Bypass Grafting
Official title Effect of Respiratory Trainer on Cardiopulmonary Functions in Patients with Upper Cross Syndrome Post-Cardiac Surgery
ClinicalTrials.gov ID: NCT06673953
What this study is testing
- What it's testing
- The purpose of this study is to investigate if there is any effect of the respiratory training on cardiopulmonary functions in patients with upper cross syndrome post-cardiac surgery. Hypothesis: Null hypothesis: There is no effect of the respiratory training on pulmonary functions in patients with upper cross syndrome post-cardiac surgery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 55, men only
You may be able to join if
- Sixty post-CABG-male-patients for at least three months and their age ranges from 45 to 55 years old.
- Craniovertebral angle \< 51°, but not less than 30°.
- Non-specific chronic neck pain: defined as neck pain without an identifiable pathological cause and attributed to poor posture without radiation to...
- VAS score between 3-7.
- Their body mass index ranges from (25 -29.9) kg/m2.
You likely can't join if
- Rheumatoid arthritis, cervical disc pathology, and traumatic neck pain.
- History of respiratory disease and clinical signs of severe cardiac events.
- Neurological disorders which affect the diaphragm.
- Patients whose BMI is less than 25, or greater than 30 kg/m2.
- Smokers.
- Values of FEV1 and FVC higher than 80%
See the full eligibility criteria
- Sixty post-CABG-male-patients for at least three months and their age ranges from 45 to 55 years old.
- Craniovertebral angle \< 51°, but not less than 30°.
- Non-specific chronic neck pain: defined as neck pain without an identifiable pathological cause and attributed to poor posture without radiation to upper limbs.
- VAS score between 3-7.
- Their body mass index ranges from (25 -29.9) kg/m2.
- Values of FEV1 and FVC lower than 80%
- Rheumatoid arthritis, cervical disc pathology, and traumatic neck pain.
- History of respiratory disease and clinical signs of severe cardiac events.
- Neurological disorders which affect the diaphragm.
- Patients whose BMI is less than 25, or greater than 30 kg/m2.
- Smokers.
- Values of FEV1 and FVC higher than 80%
- Patients with chronic obstructive pulmonary disease or asthma.
The study team makes the final eligibility decision.
Where it's taking place
- Giza, Giza Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 45 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Giza, Giza Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.